Since Sep 2024, Pharmalys have conducted an intensive series of capacity-building training sessions initially focusing on Good Clinical Practice (GCP), Good Documentation Practice (GDP), and Data Integrity, these will be followed by a clinical trial implementation and quality training in 2025.